Eupraxia Pharmaceuticals Inc. (EPRX) earnings
EPRX earnings moved a median of -1.21% by the close. Quarterly and annual EPRX reports and results, each read against the price at its own news timestamp. Back to the EPRX overview →
10 measured EPRX earnings events.
Where these EPRX earnings landedvs 10 measured EPRX earnings reactions
| Middle 50% of EPRX earnings reactions | -3.09% to +1.06% |
|---|---|
| Median reaction (to close) | -1.21% |
| Measured reactions | 10 |
Point-in-time · zero look-ahead
Half of the 10 EPRX earnings events with a measured close landed between -3.09% and +1.06%; 30% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results | Press release | -2.70% | -2.70% | |
| Eupraxia Pharmaceuticals Reports First Quarter 2026 Financial Results | Press release | -0.26% | -3.58% | |
| Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results | Press release | +0.00% | -1.34% | |
| Eupraxia Pharmaceuticals Reports Third Quarter 2025 Financial Results | Press release | -1.10% | +4.04% | |
| Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | -1.09% | -1.09% | |
| Eupraxia Pharmaceuticals Reports First Quarter 2025 Financial Results | Press release | — | -7.91% | |
| Eupraxia Pharmaceuticals Reports Fourth Quarter 2024 Financial Results | Press release | -1.01% | -3.23% | |
| Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results | Press release | — | +1.41% | |
| Eupraxia Pharmaceuticals Reports Second Quarter 2024 Financial Results | Press release | — | +2.44% | |
| Eupraxia Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update | Press release | +0.34% | +0.00% |
Keep exploring
More EPRX: analyst actions → · SEC filings → · EPRX overview →